Search

1. Rx Price Watch report: retail prices for widely used brand name drugs increase considerably prior to generic competition

Publication:

Washington, D.C. : AARP Public Policy Institute, c2011

Subject(s):

Drug Costs -- trends
Drug Therapy -- statistics & numerical data
Economic Competition
Pharmaceutical Preparations -- economics
United States

2. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

3. Some manufacturers reported inaccurate drug product data to CMS

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020

Subject(s):

Data Accuracy
Drug Industry -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services

4. Medicare Part B drug payments: impact of price substitutions based on 2019 average sales prices

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021

Subject(s):

Government Regulation
Medicare Part B -- economics
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services

5. The role of clinical and cost information in Medicaid pharmacy benefit decisions: experience in seven states

Author(s):

Gaffney, Jenny, author
Kress, Marielle, author
Pearson, Caroline, author
Carino, Tanisha, author
Connolly, John, author
Rudowitz, Robin, author

Publication:

Washington, DC : Henry J. Kaiser Family Foundation, September 2011

Subject(s):

Economics, Pharmaceutical
Insurance, Pharmaceutical Services
Medicaid -- economics
Pharmaceutical Preparations -- economics
State Health Plans -- economics
United States

6. Prescription drugs in Nebraska: a survey of experiences and opinions

Publication:

Washington, D.C. : AARP Knowledge Management, c2005

Subject(s):

Data Collection
Drug Costs
Drug Prescriptions -- economics
Pharmaceutical Preparations -- economics
Nebraska
United States

7. Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Communication
Equipment and Supplies -- economics
Insurance, Health, Reimbursement -- economics
Pharmaceutical Preparations -- economics
Truth Disclosure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration